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Sensory Nerve Innervation of Epineurial Arterioles
of the Sciatic Nerve Containing Calcitonin Gene–Related
Peptide: Effect of Streptozotocin-Induced Diabetes
M. A. Yorek, L. J. Coppey, J. S. Gellett, and E. P. Davidson
Department of Internal Medicine, University of Iowa and Veterans Affairs Medical Center,
Iowa City, Iowa, USA
The authors have determined that epineurial arteri-
oles of the sciatic nerve are innervated by nonadrenergic,
noncholinergic nerves that contribute to the regulation of
vasodilation. Using immunohistochemistry, the authors
determined that nerves innervating epineurial arterioles
contain the neuropeptide calcitonin gene–related peptide
(CGRP).Usingstreptozotocin-induceddiabeticrats,theau-
thors demonstrated that CGRP content in sensory nerves
innervating epineurial arterioles and vasodilation in re-
sponse to exogenous CGRP was decreased. In summary,
epineurial arterioles of the sciatic nerve are innervated by
sensory nerves containing the neuropeptide CGRP. The
diabetes-like condition induced by streptozotocin reduces
the content of CGRP in these nerves and exogenous CGRP-
mediated vasodilation. CGRP is likely an important regu-
lator of vascular tone and compromising its function could
contribute to nerve ischemia and diabetic neuropathy.
Keywords DiabeticComplications;DiabeticNeuropathy;Vasocon-
striction; Vasodilation
It has been reported that noradrenergic, serotoninergic, and
peptidergic nerves innervate the epineurium-perineurium vas-
culatureofperipheralnerves,andtheneurotransmittersreleased
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from these nerves regulate vascular tone and nerve blood ﬂow
[1–4]. Previously, we reported that diabetes caused impairment
in acetylcholine-mediated vasodilation in epineurial arterioles
of the sciatic nerve [5]. In the present study, we report that in-
nervation by sensory nerves containing calcitonin gene–related
peptide (CGRP) of epineurial arterioles of the sciatic nerve and
CGRP bioactivity is altered in streptozotocin-induced diabetic
rats. Impairment in innervation by sensory nerves or vascular
regulation could contribute to nerve ischemia and the progres-
sion of diabetic neuropathy.
Our studies indicate that epineurial arterioles of the sciatic
nerve are innervated with sensory afferent nerves containing
the vasoactive peptide CGRP. CGRP is a 37–amino acid neu-
ropeptide and a potent vasodilator [6]. Localization of CGRP
receptorsgenerallymatchestheCGRPpeptidedistribution,and
in the arterial system the densities of CGRP receptors from
highest to lowest has been found in the peripheral, mesenteric,
femoral, and carotid arteries [6].
In diabetes, investigators have demonstrated a variety of de-
fects associated with CGRP expression and function. In the rat
ileum,itwasfoundthatafter8weeksofdiabetes,therewasade-
crease in CGRP immunoreactivity [7]. The same investigators
found that CGRP-containing neurons were decreased in gan-
glioncellsoftheileumandproximalcolonbutnotdecreasedin
themyentericgangliaofthediabeticintestine[8].Therefore,di-
abetes appears to have differential effects on CGRP expression
along the intestinal tract [7–9]. In the trachea, diabetes caused
a reduction in CGRP release following electrical ﬁeld stimula-
tion[10,11].Likewise,after34weeksofdiabetes,thereisase-
lective decrease in CGRP-induced relaxation in the intramural
coronary arteries [12]. Lastly, Tomlinson and colleagues have
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reported that diabetes caused deﬁcits in both anterograde and
retrograde axonal transport of CGRP and a 30% to 40% de-
crease in the content of CGRP in the sciatic nerve, which was
prevented by insulin treatment [13–15].
In the present study, we report that streptozotocin-induced
diabetes of 4- to 6- and 10- to 12-week duration causes
a concentration-dependent impairment of exogenous CGRP-
induced vasodilation and diabetes of 10- to 12-week dura-
tion caused a decrease in CGRP levels in sensory nerves of
epineurial arterioles. Because neuropeptides of sensory nerves
regulate blood ﬂow to peripheral tissues, impairment of CGRP
availability and bioactivity in epineurial arterioles of the sciatic
nerve may have an impact on the development of diabetes-
related vascular and neural complications.
MATERIALS AND METHODS
Unless stated otherwise, all chemicals used in these studies
were obtained from Sigma Chemical Co. (St. Louis, MO).
Animals
MaleSprague-Dawley(HarlanSprague-Dawley,Indianapo-
lis, IN) rats, 8 to 9 weeks of age, were housed in a certiﬁed an-
imal care facility and food (Harlan Teklad, no. 7001, Madison,
WI) and water were provided ad libitum. All institutional (ap-
proval ACURF no. 0210257) and National Institutes of Health
guidelines for use of animals were followed. Diabetes was in-
duced by intravenously injecting streptozotocin (55 mg/kg in
0.9% NaCl, adjusted to a pH 4.0 with 0.2 M sodium citrate).
Control rats were injected with vehicle alone. The rats were
anesthetizedwithhalothanebeforeinjection.Diabeteswasver-
iﬁed 48 hours later by evaluating blood glucose levels with the
use of glucose-oxidase reagent strips (Lifescan, Milpitas, CA).
Rats having blood glucose level of 300 mg/dL (16.7 mM) or
greater were considered to be diabetic. After veriﬁcation of di-
abetes, 2 groups of rats were established a short-term diabetic
group (4 to 6 weeks’ duration of diabetes) and a long-term
diabetic group (10 to 12 weeks’ duration of diabetes).
On the day of the experiment, nonfast blood glucose level
was determined and the rats were anesthetized with Nembutal
intraperitoneal (IP) (50 mg/kg, IP; Abbott Laboratories, North
Chicago,IL).Afterwards,theabdominalaortawasisolatedand
occluded1to2cmabovethebranchofthecommoniliacartery.
Theratwasthensacriﬁcedbyexsanguination,andbodytemper-
atureloweredwithtopicalicefollowedbyisolationandremoval
of the epineurial arterioles for vascular studies.
Vascular Reactivity
Videomicroscopy was used to investigate in vitro vasodila-
tory responsiveness of arterioles vascularizing the region of the
sciatic nerve as previously described [5, 16, 17]. The epineurial
arterioles used for these studies were generally oriented longi-
tudinally in relation to the sciatic nerve; however, on occasion
radially oriented vessels were also used. To isolate these ves-
sels,thecommoniliacwasexposedandthebranchpointsofthe
internal pudendal and superior gluteal arteries identiﬁed. The
vessels were then clamped, and tissue containing these vessels
and its branches dissected en bloc. The block of tissue was im-
mediately submerged in a cooled (4◦C), oxygenated (20% O2,
5% CO2, and 75% N2) Krebs Henseleit physiological saline
solution (PSS) of the following composition (in mM): NaCl
118, KCl 4.7, CaCl2 2.5, KH2PO4 1.2, MgSO4 1.2, NaHCO3
20, Na2EDTA 0.026, and 5.5 glucose. Branches of the superior
gluteal and internal pudendal arteries (50 to 150 µm internal
diameter and 2 mm in length) were carefully dissected and
trimmed of fat and connective tissue. Both ends of the isolated
vessel segment were cannulated with glass micropipettes ﬁlled
with PSS (4◦C), and secured with 10-0 nylon Ethilon monoﬁl-
ament sutures (Ethicon, Cornelia, GA). The pipettes were at-
tached to a single pressure reservoir (initially set at 0 mm Hg)
under condition of no ﬂow. The organ chamber containing the
cannulated vessels was then transferred to the stage of an in-
verted microscope (CK2; Olympus, Lake Success, NY). At-
tached to the microscope were a CCTV camera (WV-BL200,
Panasonic, Secaucus, NJ), video monitor (Panasonic), and a
videocaliper(VIA-100K;BoeckelerInstruments,Tucson,AZ).
Theorganchamberwasconnectedtoarotarypump(Masterﬂex;
ColeParmerInstrument,VernonHills,IL),whichcontinuously
circulated 37◦C oxygenated PSS at 30 mL/min. The pressure
within the vessel was then slowly increased to 40 mm Hg. At
this pressure we found that KCl gave the maximal constrictor
response. Therefore, all the studies were conducted at 40 mm
Hg.Internalvesseldiameter(resolutionof2µm)wasmeasured
by manually adjusting the video micrometer. After 30 minutes’
equilibration, KCl was added to the bath to test vessel viability.
Vessels that failed to constrict more than 30% were discarded.
AfterwashingwithPSS,vesselswereincubatedfor30minutes
in PSS and then preconstricted with the thromboxane analog
U46619 (10−8 to 10−7 M) (Cayman Chemical, Ann Arbor, MI)
to 30% to 50% of passive diameter. This vasoconstrictor ago-
nist was selected because it is a receptor-mediated constrictor
that consistently produces stable vasoconstriction in rat arte-
rial vessels. There was no signiﬁcant difference in the amount
of U46619 required to induce constriction in control and dia-
betic vessels. Cumulative concentration-response relationships
wereevaluatedforCGRP(10−11 to10−8 M),andacetylcholine
(10−8 to10−4 M)usingvesselsfromcontroland/orbothgroups
of diabetic rats. At the end of each dose-response determina-
tion, sodium nitroprusside (10−4 M) was added to determine
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Immunohistochemistry
We analyzed for CGRP by immunohistochemical staining
epineurial arterioles of the sciatic nerve from control and both
groupsofdiabeticrats.Epineurialarteriolesofthesciaticnerve
were collected as described above with minimal preparation.
Afterwards,thevesselswereincubatedfor30minutesinbuffer
containing 1% Triton X-100 with 1% bovine serum albumin
[18]. The vessels were next incubated in a mixture contain-
ing goat polyclonal antibodies against CGRP for 72 hours at
4◦C. For controls, vessels were incubated in the absence of
anti-CGRP. Afterwards, vessels were washed and then incu-
bated with a mixture of Alexa-Fluor-568–conjugated donkey
anti-goatimmunoglobulinG(IgG)(MolecularProbes,Eugene,
OR)for24hoursat4◦C.Followingtheincubationwiththesec-
ondary antibody, vessels were washed with 0.01 M phosphate-
buffered saline (PBS), water, and then mounted with Vector-
Shield. The labeled vessels derived from these studies were
visualized with a Zeiss LSM 510 laser scanning confocal mi-
croscope using either 10× or 20× objectives. Optical sections
along the z-axis were collected at 1.0-µm intervals at a res-
olution of 512 × 512. Stacks of images from slices at the
same z section were combined to form a single composite
image.
To conﬁrm that CGRP levels were decreased in epineurial
arterioles from diabetic rats (10- to 12-week duration), the
CGRP content of intact vessels were analyzed using a CGRP
(rat) radioimmunoassay (RIA) kit (Phoenix Pharmaceuticals,
Belmont, CA) according to the vendor’s instructions [10, 19].
To measure CGRP content of intact vessels, epineurial arteri-
oles were pooled from 4 rats, weighed, and homogenized [10].
Levels of CGRP were reported as pg/mg wet tissue weight.
Data Analysis
The results are presented as mean ± SEM. Dose-response
curves were compared using a 2-way repeated-measure analy-
sis of variance with autoregressive covariance structure using
proc mixed program of SAS [5, 16, 17]. Whenever signiﬁcant
interactions were noted, speciﬁc treatment-dose-effect interac-
tions were analyzed using a Bonferroni adjustment. A P value
of less .05 was considered signiﬁcant.
RESULTS
Vascular Reactivity in Epineurial Arterioles
of the Sciatic Nerve
In epineurial arterioles of the sciatic nerve from normal
rats, exogenous CGRP caused vasodilation (Figure 1). CGRP-
induced vascular relaxation was blocked by 1 µM CGRP8−37,
a CGRP receptor antagonist (data not shown). Data in Figure 1
FIGURE 1
Determination of the effect of the duration of diabetes on
CGRP-mediated vascular relaxation in epineurial arterioles of
the sciatic nerve. Pressurized arterioles were preconstricted
with U46619 (30% to 50%), and incremental doses of CGRP
were added to the bathing solution while the steady-state
vessel diameter was recorded. The data are presented as the
mean ± SEM. The number of experimental observations is
noted in parentheses. ∗The response to CGRP was signiﬁcantly
different compared to control rats; +the response to CGRP was
signiﬁcantly different compared to 4- to 6-week diabetic rats.
also demonstrate that streptozotocin-induced diabetes caused a
decrease in CGRP-mediated vasodilation (∗P <. 05 compared
to control). Vasodilation induced by CGRP was impaired to a
greater extent in epineurial arterioles derived from diabetic rats
of 10- to 12-week duration compared to arterioles from 4- to
6-week diabetic rats (+P <. 05 compared to 4- to 6-week di-
abetic rats). In these studies the mean blood glucose level for
the 4- to 6-week and 10- to 12-week diabetic rats was 412 ± 36
and 441 ± 34 mg/dL, respectively. Control rats had an average
blood glucose level of 101 ± 10 mg/dL.
Previously, we had demonstrated that the acetylcholine-
induced vascular relaxation in epineurial arterioles of the
sciatic nerve was endothelium dependent [5]. However, as
demonstrated in Figure 2, CGRP-induced vascular relax-
ation was endothelium independent. Stripping the endothelium
from epineurial arterioles of the sciatic nerve did not effect
CGRP-induced vascular relaxation. In contrast, acetylcholine-
mediated vascular relaxation was attenuated by removal of the
endothelium.
Immunohistochemical Staining for CGRP
in Epineurial Arterioles of the Sciatic Nerve
To conﬁrm the presence of CGRP-containing neurons
in epineurial arterioles, we conducted immunohistochemical190 M. A. YOREK ET AL.
FIGURE 2
Determination of the effect of the endothelium on CGRP- or
acetylcholine-mediated vascular relaxation in epineurial
arterioles of the sciatic nerve. Epineurial arterioles were
denuded, pressurized, and then preconstricted with U46619
(30% to 50%). Incremental doses of acetylcholine or CGRP
were then added to the bathing solution while the steady-state
vessel diameter was recorded. The data are presented as the
mean ± SEM. The number of experimental observations is
noted in parentheses.
staining studies using arterioles from control rats. We also
examined the effect of streptozotocin-induced diabetes on the
presence of CGRP-containing sensory nerves in these vessels.
DatainFigure3demonstratethespeciﬁcityofimmunostaining
forCGRPinepineurialarteriolesfromcontrolrats.Incubations
FIGURE 3
Data are presented for the immunohistochemical staining of CGRP (red)i nthe presence (left) and absence (right)o ft h e
primary antibody in epineurial arterioles of the sciatic nerve from a control rat.
were performed in the presence (left panel)o rabsence (right
panel)o fthe primary antibody. Figure 4 present results for
immunostaining for CGRP-sensory nerves in epineurial arteri-
oles of the sciatic nerve from control (top) and 10- to 12-week
diabetic rats (bottom). CGRP immunostaining was reduced in
epineurial arterioles from streptozotocin-induced diabetic rats
after10to12weeksofdiabetes.Similarstudiesconductedwith
epineurial arterioles from 4- to 6-week diabetic rats indicated
no apparent decrease in CGRP levels (data not shown). The
decrease in CGRP levels in epineurial arterioles from 10- to
12-week diabetic rats was also examined using a CGRP ra-
dioimmunoassay (Figure 5). Data in Figure 5 demonstrate that
the content of CGRP in sensory nerves of rat epineurial arteri-
olesfollowing12weeksofstreptozotocin-induceddiabeteswas
reducedbyabout75%comparedtoCGRPlevelsinnormalrats.
In one experiment with epineurial arterioles from 4-week dia-
betic rats, the amount of CGRP present was similar to control
rats (data not shown).
DISCUSSION
These studies demonstrate that nerve fascicles innervat-
ing epineurial arterioles of the sciatic nerve are immunore-
active for CGRP. Furthermore, our studies have shown that
streptozotocin-induced diabetes, 10- to 12-week duration,
causedbothadecreaseintheCGRPcontentinepineurialarteri-
oles and the ability of exogenous CGRP to induce vasodilation.
Ourdatademonstratethatlong-termstreptozotocin-induced
diabetes caused a dual defect in epineurial arterioles of the sci-
atic nerve that would likely lead to impaired CGRP-mediated
vascular function. First, we observed that diabetes caused aCGRP IN EPINEURIAL ARTERIOLES OF THE DIABETIC RAT 191
FIGURE 4
Determination of the effect of diabetes on CGRP content in
epineurial arterioles of the sciatic nerve. Data are presented
for the immunohistochemical staining of CGRP (red)i n
epineurial arterioles of the sciatic nerve from 2 separate
control (top) and 10- to 12-week diabetic (bottom) rats.
decrease in the level of CGRP in sensory nerves innervating
epineurial arterioles of the sciatic nerve. Other investigators
have also found that diabetes caused a decrease in CGRP con-
tent of the sciatic, vagus, and enteric nerves [10, 13–15, 20].
Furthermore,Rittenhouseandcolleagueshavereportedthatthe
synthesis of CGRP was decreased in the dorsal root ganglion
of streptozotocin-induced diabetic rats [21]. Our result demon-
strating that CGRP levels are decreased in long-term diabetic
rats is also consistent with the studies by Zochodne and Ho
[22, 23]. They demonstrated that a topical application of cap-
saicin caused a hyperemic response of endoneurial blood ﬂow
in control rats, which was due to a release of CGRP. However,
in streptozotocin-induced diabetic rats after 4 months of hyper-
glycemia, the hyperemic response to capsaicin was attenuated.
The decrease in CGRP levels could be due to a decrease in
the transport of CGRP to nerve endings or a denervation of
sensory nerves. Tomlinson and colleagues have reported that
anterograde transport of CGRP in sciatic nerves was decreased
FIGURE 5
Determination of the effect of 12 weeks of diabetes on CGRP
content in epineurial arterioles of the sciatic nerve. Epineurial
arterioles from 4 control and 12-week diabetic rats were
pooled and examined for CGRP content using a
radioimmunoassay for rat CGRP. The data are presented as the
mean ± SEM. The number of experimental observations is
noted in parentheses. ∗The CGRP content of epineurial
arterioles from 12-week diabetic rats was signiﬁcantly
different compared to control rats.
in diabetes [13–15, 24]. The studies conducted by Tomlinson
and colleagues focused on the entire sciatic nerve. Whether a
similar defect in CGRP transport can be isolated to the sen-
sory nerves innervating the epineurial arterioles of the sciatic
nerveremainstobedetermined.Second,ourstudieshaveshown
that exogenous CGRP-mediated vasodilation was impaired by
streptozotocin-induced diabetes. Vasodilation by epineurial ar-
terioles in response to a low dose of exogenous CGRP was
impaired after 4 to 6 weeks of diabetes and at all doses of ex-
ogenous CGRP after 10 to 12 weeks of diabetes. Our results
agree with the studies of Sheykhzade and colleagues that re-
ported that long-term diabetes caused a selective depression
of αCGRP-induced relaxation in intramural coronary arteries
of Wistar rats [25]. Sheykhzade and colleagues [12] suggested
that the diabetes-induced impairment of CGRP-mediated vas-
cularrelaxationincoronaryarteriesmaybeduetoglycosylation
and/or conformational changes of the CGRP receptor. More-
over, it has been demonstrated that the vasodilatory response to
CGRP involves the formation of cyclic adenosine monophos-
phate (cAMP) and activation of Ca2+ signaling pathways
[1, 2, 25, 26]. It is possible that the signaling mechanism(s)
activated by the CGRP receptor may be impaired in diabetes,
thereby causing a decrease in vasodilation in response to ex-
ogenous CGRP. This would be supported by our data, which
demonstrate that at a low dose of CGRP and shorter duration192 M. A. YOREK ET AL.
FIGURE 6
Representation of epineurial arterioles and innervation by sensory nerves containing CGRP: effect of diabetes.
of diabetes, vasodilation in response to exogenous CGRP is
attenuated but is normal at a higher dose of CGRP. It is only
after a longer duration of diabetes that vasodilation in response
to all concentrations of CGRP is impaired. Additional studies
will be required to address these issues.
Figure 6 provides a summary of our interpretation of the
results from these studies. Epineurial arterioles of the sciatic
nerve from a normal rat are innervated by sensory nerves that
contain CGRP. These sensory nerves appear to be localized be-
tween the smooth muscle and adventitia. In long-term diabetic
rats, the amount of CGRP present in epineurial arterioles is di-
minished. This could be due to a decrease in axonal transport
of CGRP from the dorsal root ganglion cells or denervation
of the sensory neurons. In addition to the decrease in CGRP
levels in sensory nerves innervating epineurial arterioles, dia-
betes also causes impairment in CGRP-mediated vasodilation.
Exogenous CGRP likely reacts with a calcitonin receptor–like
receptorlocatedonsmoothmusclecellsandcausesvasodilation
in epineurial arterioles by an unknown mechanism. Diabetes,
in a duration sensitive manner, appears to impair this mecha-
nism. Perhaps diabetes is causing a decrease in the number of
receptors and/or impairing the signaling mechanism regulating
CGRP-mediated vascular relaxation. Overall, impairment of
CGRPlevelsandbioactivitycouldhaveanimpactonthedevel-
opmentandprogressionofdiabeticneuropathybecausetheneu-
ropeptides released by sensory nerves are thought to regulate
vascular tone and blood ﬂow to peripheral nerves [3, 4, 27, 28].
Compromising the level and function of these neuropeptides
could contribute to nerve ischemia and morphological changes
observed during the progression of diabetic neuropathy.
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